Pliant Therapeutics, Inc. · NASDAQ:PLRX
Woodline Partners LP reported a 7.30% stake in Pliant Therapeutics, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 14, 2025
Woodline Partners LP reported a 7.30% stake in Pliant Therapeutics, Inc., 4,504,817 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).
- Stake
- 7.30%
- Shares
- 4,504,817
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Woodline Partners LP | 7.30% | 4,504,817 |
Source
Related
- Pliant Therapeutics, Inc.
- Woodline Partners LP
- Pliant Therapeutics, Inc. shareholders
- Schedule 13G/A · Woodline Partners LP · Feb 17, 2026
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Feb 17, 2026
- Schedule 13G · Citadel Advisors LLC · Feb 9, 2026
- Schedule 13G · Citadel Advisors LLC · Jan 30, 2026